| Non-Hodgkin’s B-cell lymphoma: advances in molecular strategies targeting drug resistance SA Maxwell, S Mousavi-Fard Experimental Biology and Medicine 238 (9), 971-990, 2013 | 64 | 2013 |
| Metformin attenuates oxidative stress and liver damage after bile duct ligation in rats H Sadeghi, F Jahanbazi, H Sadeghi, N Omidifar, B Alipoor, EP Kokhdan, ... Research in pharmaceutical sciences 14 (2), 122-129, 2019 | 50 | 2019 |
| Design and characterization of paclitaxel-verapamil co-encapsulated PLGA nanoparticles: Potential system for overcoming P-glycoprotein mediated MDR H Afrooz, F Ahmadi, F Fallahzadeh, SH Mousavi-Fard, S Alipour Journal of Drug Delivery Science and Technology, 2017 | 27 | 2017 |
| Mutations in the E2 and NS5A regions in patients infected with hepatitis C virus genotype 1a and their correlation with response to treatment N Yahoo, F Sabahi, K Shahzamani, MA Malboobi, H Jabbari, H Sharifi, ... Journal of medical virology 83 (8), 1332-1337, 2011 | 10 | 2011 |
| Development of a SYBR green real time multiplex RT-PCR technique for simultaneous detection of HCV and GBV-C Co-infection in plasma samples SH Mousavi Fard, S Merat, K Shahzamani, R Ghanbari, F Sabahi Molecular and Biochemical Diagnosis Journal 1 (1), 41-49, 2014 | 4 | 2014 |
| Development of novel, non-toxic rifamycins that reverse drug resistance SA Maxwell, D Wallis, N Zhou, D Baker, SH Mousavi-Fard, K Loesch, ... Cancer Research 82 (12_Supplement), 410-410, 2022 | | 2022 |
| Development of Novel, Non-Toxic Rifamycins that Reverse Drug Resistance in Diffuse Large B-cell Lymphoma (DLBCL) S Maxwell, D Wallis, N Zhou, D Baker, SH Mousavi-Fard, K Loesch, ... Hematological Oncology 35, 253-254, 2017 | | 2017 |
| Downregulation of the G6PDH Pathway Can Promote Oxidative Stress‐Mediated Reversal of Drug Resistance in B‐Cell Lymphoma cell Lines SH Mousavi‐fard The FASEB Journal 30, 606.7-606.7, 2016 | | 2016 |
